Relationship between undetectable PSA nadir and outcomes for patients with metastatic hormone sensitive prostate cancer in IRONMAN, the International Registry for Men with Advanced Prostate Cancer
Hannah McManus et al.
Poster presented at ASCO GU 2025
Impact of first-line hormone therapies at enrollment and subjective cognitive function over time among metastatic prostate cancer survivors: an international study
Michelle Sodipo
AACR 2025
The International Registry for Men with Advanced Prostate Cancer
Mucci, L. et al
Poster presented at: ASCO Genitourinary Cancers Symposium; 2023 Jan 19-21; San Francisco, CA
Marital status, living arrangement, and overall survival among individuals with advanced prostate cancer in the IRONMAN cohort
Chen, N. et al
Poster presented at: AACR Annual Meeting; 2023 Apr 14-19; Orlando, FL
Click here to view the abstract
The International Registry for Men with Advanced Prostate Cancer
George, D.J. et al
Poster presented at: ASCO Genitourinary Cancers Symposium; 2022 Feb 17-19; San Fransisco, CA.
Click here to view the abstract
First Look at Patient Reported Outcomes from IRONMAN, the International Registry of Men with Advanced Prostate Cancer
Rencsok, E., et al
Poster presented at: ASCO Genitourinary Cancers Symposium; 2022 Feb 17-19; San Fransisco, CA.
Click here to view the conference
First 500 Patients of IRONMAN: International Registry for Men with Advanced Prostate Cancer
George, D.J. et al
Poster presented at: PCF Annual Scientific Retreat; 2019 Oct 24-26; Carlsbad, CA
Click here to view the abstract
Patient Reported Outcomes Ameng Men with Advanced Prostate Cancer: Results from the IRONMAN Registry
Mucci, L. et al
Poster presented at: PCF Annual Scientific Retreat; 2019 Oct 24-26; Carlsbad, CA
Click here to view the abstract